title: Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.
abstract: The prostaglandin endoperoxide synthase (PTGS) pathway is a potent driver of tumour development in humans by enhancing the biosynthesis and signalling of prostaglandin (PG) E(2). PTGS2 expression and PGE(2) biosynthesis is elevated in endometrial adenocarcinoma, however the mechanism whereby PTGS and PGE(2) regulate endometrial tumour growth is unknown. Here we investigated (a) the expression profile of the PGE synthase enzymes (PTGES, PTGES-2, PTGES-3) and PGE receptors (PTGER1-4) in endometrial adenocarcinomas compared with normal endometrium and (b) the role of PTGER4 in endometrial tumorigenesis in vivo. We found elevated expression of PTGES2 and PTGER4 and suppression of PTGER1 and PTGER3 in endometrial adenocarcinomas compared with normal endometrium. Using WT Ishikawa endometrial adenocarcinoma cells and Ishikawa cells stably transfected with the full length PTGER4 cDNA (PTGER4 cells) xenografted in the dorsal flanks of nude mice, we show that PTGER4 rapidly and significantly enhances tumour growth rate. Coincident with enhanced PTGER4-mediated tumour growth we found elevated expression of PTGS2 in PTGER4 xenografts compared with WT xenografts. Furthermore we found that the augmented growth rate of the PTGER4 xenografts was not due to enhanced angiogenesis, but regulated by an increased proliferation index and hypoxia. In vitro, we found that PGE(2) and hypoxia independently induce expression of PTGER4 indicating two independent pathways regulating prostanoid receptor expression. Finally we have shown that PGE(2) and hypoxia synergise to promote cellular proliferation of endometrial adenocarcinoma cells.
authors: Medical Research Council Human Reproductive Sciences Unit, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
authors: Rob D
authors: RD
authors: Catalano
authors: Martin R
authors: MR
authors: Wilson
authors: Sheila C
authors: SC
authors: Boddy
authors: Andrew T M
authors: AT
authors: McKinlay
authors: Kurt J
authors: KJ
authors: Sales
authors: Henry N
authors: HN
authors: Jabbour
references: Cell Signal. 2010 Jan;22(1):71-9
references: 19782748
references: Int J Gynecol Cancer. 2007 Jul-Aug;17(4):897-904
references: 17359291
references: Br J Cancer. 2001 Sep 28;85(7):1023-31
references: 11592775
references: J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):221-9
references: 18061438
references: Cancer Cell. 2003 Oct;4(4):257-62
references: 14585353
references: Prostaglandins Leukot Essent Fatty Acids. 1996 Sep;55(3):179-83
references: 8931116
references: Int J Oncol. 2004 May;24(5):1311-24
references: 15067356
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Exp Cell Res. 2007 Aug 15;313(14):2969-79
references: 17631291
references: Neoplasia. 2000 Nov-Dec;2(6):483-90
references: 11228540
references: J Exp Ther Oncol. 2008;7(4):299-312
references: 19227010
references: Fertil Steril. 2019 Oct;112(4 Suppl1):e93-e115
references: 31623748
references: J Cell Biochem. 2009 Sep 1;108(1):207-15
references: 19582788
references: Biochim Biophys Acta. 2009 Dec;1793(12):1917-28
references: 19819266
references: Trends Pharmacol Sci. 2003 Jul;24(7):335-40
references: 12871665
references: Cell. 1995 Nov 3;83(3):493-501
references: 8521479
references: Mol Med. 2001 Oct;7(10):685-97
references: 11713368
references: Mini Rev Med Chem. 2009 Aug;9(9):1084-101
references: 19689405
references: Hum Pathol. 2007 Aug;38(8):1232-8
references: 17490724
references: J Biol Chem. 2003 Sep 26;278(39):37937-47
references: 12835322
references: J Clin Endocrinol Metab. 2004 Dec;89(12):6112-8
references: 15579767
references: Cell. 1998 May 29;93(5):705-16
references: 9630216
references: Cancer Res. 2003 May 1;63(9):2330-4
references: 12727858
references: Cancer Res. 2002 Jan 15;62(2):424-32
references: 11809691
references: Am J Pathol. 2010 Jan;176(1):435-45
references: 20008143
references: Mol Hum Reprod. 2011 Mar;17(3):182-92
references: 21112968
references: Cancer Res. 2009 Feb 1;69(3):896-904
references: 19176380
references: Mol Cell Endocrinol. 2008 Mar 26;285(1-2):51-61
references: 18316157
references: Semin Oncol. 2004 Apr;31(2 Suppl 7):2-11
references: 15179620
references: Trends Mol Med. 2003 Feb;9(2):73-8
references: 12615041
references: J Clin Pathol. 2008 Jan;61(1):36-42
references: 17483252
references: Cancer Res. 2006 Mar 15;66(6):3106-13
references: 16540660
references: Int J Mol Med. 1998 Dec;2(6):715-9
references: 9850741
references: Cancer Res. 2006 Mar 15;66(6):2923-7
references: 16540639
references: J Biol Chem. 1999 Aug 13;274(33):22903-6
references: 10438452
references: Curr Top Microbiol Immunol. 2010;345:105-20
references: 20517715
references: Trends Endocrinol Metab. 2004 Oct;15(8):398-404
references: 15380812
references: Annu Rev Pathol. 2007;2:57-85
references: 18039093
references: J Exp Med. 2006 Apr 17;203(4):941-51
references: 16567391
references: Life Sci. 2003 Dec 5;74(2-3):143-53
references: 14607241
references: J Clin Invest. 2003 Oct;112(8):1134-6
references: 14561696
references: Physiol Rev. 1999 Oct;79(4):1193-226
references: 10508233
references: Cancer Res. 1996 Feb 15;56(4):733-7
references: 8631005
references: Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):112-20
references: 17259077
references: Cancer Res. 2008 Jul 15;68(14):5619-27
references: 18632614